One of the missions of NewG Lab Pharma (NGLP) is to develop novel anticancer therapeutics that extend the life of cancer patients without compromising their quality of life.
FIELD OF BUSINESS
under the goal
overall survival increase
History of Dr. Ko
Professor Pedersen (Left) Dr. Ko (Middle) James Dewey Watson (Right)
Dr. Ko has conducted research at various Universities and as an independent entity.
Dr. Ko and Prof. Pedersen are working together since 1991.
Master of Science Student at Iowa State University, Pre-Doctoral Student at Washington State University, Post-Doctoral Fellow at John Hopkins University, Assistant Professor at John Hopkins University, Independent Research and Global Cooperation - Germany, Belgium, Poland, Portugal, the Netherlands and Korea.
NCI and NIH Mitochondria Interest Group Seminar: Johns Hopkins’ Pedersen Ad…
Cancer and Metabolic Disease by Thomas Seyfried : On the Origin, Manageme…
NEWGLAB Notice page.